LifeX, a healthcare data intelligence company, has been finally selected for 'Unicorn Bridge,' a promising startup nurturing program by the Ministry of SMEs and Startups. LifeX was selected as a participating company in the '2026 Unicorn Bridge' in recognition of its technological capabilities to connect and analyze health data generated from medical institutions and daily life, as well as its business achievements in the global market. Unicorn Bridge is a government support program introduced for the first time this year to support the global expansion and scale-up of promising companies in deep tech fields such as AI, bio, and healthcare. Selected companies are provided with various forms of support for pioneering global markets and expanding their businesses. Global expansion as a pregnancy and rare disease data platform LifeX’s core competitive advantage lies in its 'Data Intelligence' technology, which transforms health data into a form that users can easily understand and utilize. In particular, the fetal growth indicator analysis function is implemented based on proprietary medical ultrasound image processing technology and AI. It is compatible with over 95% of major global diagnostic devices and automatically structures ultrasound images to provide analysis results in accordance with World Health Organization (WHO) standards. This technology serves as the foundation for LifeX’s flagship services: the pregnancy and parenting platform 'Mamitalk' and the cancer and rare disease patient support platform 'RareNote'. Mamitalk is a service that provides health information necessary for the entire process of pregnancy, childbirth, and child-rearing, including AI growth analysis based on fetal ultrasound images. Rarenote provides disease information, the status of treatment development, and clinical trial information to patients with cancer and rare diseases and their families, and collaborates with global pharmaceutical companies such as AstraZeneca and Novartis. Based on service operation experience accumulated in Korea, LifeX has expanded its business into